Disease burden of myasthenia gravis in relation to oral corticosteroid dose: an insurance claims database study in Japan

OCS dose target non-achievers carry a higher burden than achievers. Broader implementation of effective treatment strategies is required to reduce long-term use of higher-dose OCS and the associated burden.